Mesoblast (MESO) Cash from Operations (QoQ) (2016 - 2023)
Mesoblast (MESO) Cash from Operations (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -0.17% |
| Mar 31, 2023 | 1.24% |
| Dec 31, 2022 | -15.17% |
| Sep 30, 2022 | -2.83% |
| Jun 30, 2022 | 10.19% |
| Mar 31, 2022 | 15.09% |
| Dec 31, 2021 | -0.11% |
| Sep 30, 2021 | 3.81% |
| Jun 30, 2021 | 22.68% |
| Mar 31, 2021 | 19.98% |
| Dec 31, 2020 | -8.57% |
| Sep 30, 2020 | -106.58% |
| Jun 30, 2020 | 31.47% |
| Mar 31, 2020 | -1,395.86% |
| Dec 31, 2019 | 91.45% |
| Sep 30, 2019 | 18.48% |
| Jun 30, 2019 | 9.92% |
| Mar 31, 2019 | -1,144.31% |
| Dec 31, 2018 | 110.38% |
| Sep 30, 2018 | 3.19% |